基于证据的微脉冲经巩膜激光治疗共识指南系列——手术技术、术后护理、预期结果及再次治疗/强化治疗
Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements.
作者信息
Grippo Tomas M, Töteberg-Harms Marc, Giovingo Michael, Francis Brian A, de Crom Ronald R M P C, Jerkins Brian, Brubaker Jacob W, An Jella, Radcliffe Nathan, Noecker Robert
机构信息
Grippo Glaucoma and Cataract Center, Buenos Aires, Argentina.
Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
出版信息
Clin Ophthalmol. 2023 Jan 6;17:71-83. doi: 10.2147/OPTH.S389198. eCollection 2023.
PURPOSE
To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT).
METHODS
A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT.
RESULTS
The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript.
CONCLUSION
Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
目的
提供关于微脉冲经巩膜激光治疗（TLT）的治疗技术、术后护理、预期结果及再次治疗的专家共识和基于证据的现行指南。
方法
对PubMed进行全面检索，从而识别并分析了61项关于微脉冲TLT的研究。为在文献不足的领域提供指导，采用三轮德尔菲法，涉及10位微脉冲TLT领域的国际专家。
结果
德尔菲法第一轮的回复率为70%，第二轮为70%，第三轮为80%。汇总所有回复后，召开了一次出席率达90%的现场会议，并就本手稿中详细阐述的各项研究结果达成了共识。
结论
在适当的治疗参数范围内，采用适当的技术并进行合适的患者选择，微脉冲TLT对多种类型和严重程度的青光眼是一种安全有效的治疗方法。微脉冲TLT是青光眼治疗手段中的一项有益补充。
Zotero 插件